Vimarsana
Biggest News Aggregation in the World

Page 44 - Platform Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Platform Technology Today - Breaking & Trending Today

John Baldoni, ex-GSK R&D Leader, Joins BioSymetrics as Strategic Advisor - Vimarsana News

John Baldoni, ex-GSK R&D Leader, Joins BioSymetrics as Strategic Advisor

/PRNewswire/ -- BioSymetrics, a phenomics-driven AI drug discovery company, today announced that John Baldoni will join its strategic advisory board. John is a...

Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022 - Vimarsana News

Aptabio to present results of Isuzinaxib Phase 2 study at The American Society of Nephrology (ASN)'s Kidney Week 2022

Aptabio's Isuzinaxib (APX-115) proves its effect on a key kidney function marker in a Phase 2 clinical study in patients with diabetes and chronic kidney...

Natural Topical Pain-Reliever Proflexa Receives Official OTC Status - Vimarsana News

Natural Topical Pain-Reliever Proflexa Receives Official OTC Status

/PRNewswire/ -- Sinoveda is a Canadian-based health-science brand that is blazing an innovative trail toward the future of healthcare. The company has...

Synaffix Licenses CliCr Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering - Vimarsana News

Synaffix Licenses CliCr Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering

Synaffix obtains exclusive rights to the CliCr technology, to combine with its proprietary ADC platform technology CliCr further expands the repertoire of payloads suitable for conjugation by

Synaffix Licenses CliCr® Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering - Vimarsana News

Synaffix Licenses CliCr® Chemistry from Cristal Therapeutics to Fortify Best-in-Class ADC Technology Offering

/PRNewswire/ -- Synaffix B.V. (Synaffix), a biotechnology company focused on commercializing its clinical-stage platform technology for the development of...